Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Sanofi ADR (SNYy)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Sanofi ADR historical data, for real-time data please try another search
43.00 +0.20    +0.47%
05/10 - Delayed Data. Currency in EUR ( Disclaimer )
Type:  Equity
Market:  Germany
ISIN:  US80105N1054 
S/N:  662283
  • Volume: 0
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 43.00 - 43.00
Sanofi ADR 43.00 +0.20 +0.47%

NASDAQ:SNYy Financials

 
A brief overview of the NASDAQ:SNY financials. This summary provides an overview of the most significant critical numbers from each of its financial reports, including the income statement, balance sheet, and cash flow statement. Additionally, it features several financial ratios that provide insight into the company's financial health. Users can select to view data from four periods of either annual or quarterly information, allowing them to track financial performance of Sanofi ADR over time.

For the six months ended 30 June 2016, Sanofi SA (ADR) revenues decreased 4% to EUR16.24B. Net income before extraordinary items decreased 12% to EUR1.96B. Revenues reflect Pharmaceuticals segment decrease of 5% to EUR14.63B, Latin America segment decrease of 33% to EUR1.15B, Japan segment decrease of 22% to EUR850M. Net income also reflects Restructuring costs and similar items increase of 65% to EUR627M (expense).

AnnualQuarterly  
InvestingPro Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

SNYy Income Statement

Gross margin TTM -
Operating margin TTM -
Net Profit margin TTM -
Return on Investment TTM -
 Total Revenue  Net Income
Period Ending: Mar 31, 2015 Dec 31, 2014 Sep 30, 2014 Jun 30, 2014
Total Revenue 8890 9170 8868 8146
Gross Profit 6104 6129 6004 5538
Operating Income 1403 1685 1784 1246
Net Income 1023 1339 1190 777

SNYy Balance Sheet

Quick Ratio MRQ -
Current Ratio MRQ -
LT Debt to Equity MRQ -
Total Debt to Equity MRQ -
 Total Assets  Total Liabilities
Period Ending: Mar 31, 2015 Dec 31, 2014 Sep 30, 2014 Jun 30, 2014
Total Assets 97392 90720
Total Liabilities 41272 39083
Total Equity 56120 51637

SNYy Cash Flow Statement

Cash Flow/Share TTM -
Revenue/Share TTM -
Operating Cash Flow  -
 Cash  Net Change in Cash
Period Ending: Mar 31, 2015 Dec 31, 2014 Sep 30, 2014 Jun 30, 2014
Period Length: 0 Months 12 Months 0 Months 0 Months
Cash From Operating Activities 7690
Cash From Investing Activities -3460
Cash From Financing Activities -5180
Net Change in Cash -916
* In Millions of (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

SNY Comments

Write your thoughts about Sanofi SA
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Moshe Ohr
Moshe Ohr Aug 10, 2022 11:18AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Any idea what is behind the price change today?Thank you!
Moshe Ohr
Moshe Ohr Jul 28, 2022 3:01AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Good News 🗞️
gino freeboter
gino freeboter May 03, 2021 9:45AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
what is going on?why drop 4% inpremarket?
Aspar Badur
Aspar Badur May 03, 2021 9:45AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
don’t know 🤷‍♂️
Päivi Saarela
Päivi Saarela Apr 26, 2021 8:23AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
NEWS: Sanofi agrees to make Moderna COVID-19 vaccine in the U.S. starting in September
Brad Eff
Brad Eff Mar 31, 2021 10:10AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Announcement RIGHT NOW about a +$900 Million investment in Canada
Akposiegbe Kelvin
Akposiegbe Kelvin Feb 14, 2021 10:28AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
sanofi said it's vaccine will be available next year..
Renata Hoffmann
Renata Hoffmann Feb 14, 2021 10:28AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
but they have more products in pipeline...not just the vaccine
Renata Hoffmann
Renata Hoffmann Feb 11, 2021 8:57AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Whi is it falling? FDA approval end its going down?
Omprakash Maurya
Omprakash Maurya Feb 05, 2021 10:18AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Next target 52 buy at 48
Tejasvi Gogna
Tejasvi Gogna Aug 13, 2020 7:05PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
ARPO a small stock has given me 22% rise , that too on a day when all others have disappointed . Nova , Mrna , Bntx , Astra , Sanofi ... Seriously I salute to the guys running ARPO. .. its been so stable when all others are horribly unpredictable. ARPO has hd its base value and maintained its 1.5 level and Now its on 1.83 and after market is up again. highly recommended if someone wants to invest 1000 dollars and forget it for a while , I am sure its worth putting your 💰......
RoB Wanger
RoB Wanger Jul 31, 2020 11:33AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
https://ca.finance.yahoo.com/news/u-pay-2-1-billion-122206294.html
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email